♥
ISIN : INE768C01010
NSE : ZYDUSWELL
BSE : 531335
Face Value : 10
Industry : Consumer Food
EPS : 41.94
EPS (TTM) : 47.81
Price to Earning (P/E) : 40.07
Book Value : 842.37
Price to Bookvalue (P/B) : 1.99
Dividend Yield : 0 %
Return on Equity (ROE) : 5.09 %
Return on Capital Employed (ROCE) : 5.12 %
Zydus Wellness Limited
ISIN : INE768C01010
NSE : ZYDUSWELL
BSE : 531335
Face Value : 10
Industry : Consumer Food
EPS : 41.94
EPS (TTM) : 47.81
Price to Earning (P/E) : 40.07
Book Value : 842.37
Price to Bookvalue (P/B) : 1.99
Dividend Yield : 0 %
Return on Equity (ROE) : 5.09 %
Return on Capital Employed (ROCE) : 5.12 %
Zydus Wellness share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 423.2 - 444 4.9 % |
| Low / High | 420.1 - 448.2 6.7 % |
| Trade Volume | 32,453 |
| 52 Week Low / High | 357.55 - 2634.25 636.8 % |
-
YOU MAY ALSO LIKE
- CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - Share Market basics for beginners
Share Market jargons in simple terms - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - Stock market course tutorial
Stock Market Investment Course explained in simple words.
CONSOLIDATED QUARTERLY RESULT FOR ZYDUS WELLNESS LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 6397.8 | 6967.6 | 4294.7 | 4155.8 | 7129.8 | 7021 | 4399 | 4032 | 7826 | 8410 |
| Total Income | 6417.4 | 6987.1 | 4308.2 | 4164.2 | 7137 | 7045 | 4440 | 4066 | 7867 | 8460 |
| Total Expenditure | 4982.8 | 5486.4 | 4132.1 | 3873.9 | 5684 | 5856 | 4231 | 3905 | 6205 | 6857 |
| Other Income | 19.6 | 19.5 | 13.5 | 8.4 | 7.2 | 24 | 41 | 34 | 41 | 50 |
| Operating Profit | 1434.6 | 1500.7 | 176.1 | 290.3 | 1453 | 1189 | 209 | 161 | 1662 | 1603 |
| Interest | 59.8 | 41.4 | 29.4 | 38.4 | 51.6 | 51 | 65 | 63 | 61 | 36 |
| Exceptional Items | -29.1 | -142 | ||||||||
| PBDT | 1374.8 | 1430.2 | 146.7 | 251.9 | 1401.4 | 996 | 144 | 98 | 1601 | 1567 |
| Depreciation | 60.8 | 60.4 | 64.3 | 58.8 | 66.7 | 62 | 58 | 61 | 57 | 51 |
| Profit Before Tax | 1314 | 1369.8 | 82.4 | 193.1 | 1334.7 | 934 | 86 | 37 | 1544 | 1516 |
| Tax | -19 | -0.3 | -2.3 | -2.5 | -190 | -170 | 27 | 34 | 41 | 39 |
| Profit After Tax | 1333 | 1370.1 | 84.7 | 195.6 | 1524.7 | 1104 | 59 | 3 | 1503 | 1477 |
| Net Profit | 1333 | 1370.1 | 84.7 | 195.6 | 1524.7 | 1104 | 59 | 3 | 1503 | 1477 |
| Equity Capital | 636.3 | 636.3 | 636.3 | 636.3 | 636.3 | 636 | 636 | 636 | 636 | 636 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 20.95 | 21.53 | 1.33 | 3.07 | 22.84 | 17.36 | 0.93 | 0.05 | 23.63 | 23.22 |
| Diluted Eps After Extraordinary Items | 20.95 | 21.53 | 1.33 | 3.07 | 22.84 | 17.35 | 0.93 | 0.05 | 23.62 | 23.21 |
| Diluted Eps Before Extraordinary Items | 20.95 | 21.53 | 1.33 | 3.07 | 22.84 | 17.35 | 0.93 | 0.05 | 23.62 | 23.21 |
STANDALONE QUARTERLY RESULT FOR ZYDUS WELLNESS LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 604.3 | 618 | 672.2 | 637.2 | 587.4 | 601 | 578 | 638 | 631 | 634 |
| Total Income | 639.8 | 655.1 | 701.1 | 670.6 | 623.2 | 642 | 624 | 684 | 679 | 682 |
| Total Expenditure | 567.9 | 563.9 | 547.3 | 513.7 | 506.8 | 529 | 503 | 530 | 557 | 581 |
| Other Income | 35.5 | 37.1 | 28.9 | 33.4 | 35.8 | 41 | 46 | 46 | 48 | 48 |
| Operating Profit | 71.9 | 91.2 | 153.8 | 156.9 | 116.4 | 113 | 121 | 154 | 122 | 101 |
| Interest | 4.9 | 4.5 | 0.1 | 5.5 | 1.3 | 8 | 9 | 9 | 8 | |
| PBDT | 67 | 86.7 | 153.7 | 151.4 | 115.1 | 113 | 113 | 145 | 113 | 93 |
| Depreciation | 7.7 | 7.2 | 10.6 | 7.4 | 10 | 9 | 9 | 9 | 9 | 9 |
| Profit Before Tax | 59.3 | 79.5 | 143.1 | 144 | 105.1 | 104 | 104 | 136 | 104 | 84 |
| Tax | -74.8 | -4.7 | -6.3 | -181.5 | 22 | 26 | 33 | 30 | 22 | |
| Profit After Tax | 134.1 | 79.5 | 147.8 | 150.3 | 286.6 | 82 | 78 | 103 | 74 | 62 |
| Net Profit | 134.1 | 79.5 | 147.8 | 150.3 | 286.6 | 82 | 78 | 103 | 74 | 62 |
| Equity Capital | 636.3 | 636.3 | 636.3 | 636.3 | 636.3 | 636 | 636 | 636 | 636 | 636 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | 2.11 | 1.25 | 2.32 | 2.36 | 4.5 | 1.29 | 1.23 | 1.62 | 1.16 | 0.97 |
| Diluted Eps After Extraordinary Items | 2.11 | 1.25 | 2.32 | 2.36 | 4.5 | 1.29 | 1.23 | 1.62 | 1.16 | 0.97 |
| Diluted Eps Before Extraordinary Items | 2.11 | 1.25 | 2.32 | 2.36 | 4.5 | 1.29 | 1.23 | 1.62 | 1.16 | 0.97 |
CONSOLIDATED ANNUAL RESULT FOR ZYDUS WELLNESS LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 20091 | 22547.9 | 23278 |
| Total Income | 20195 | 22596.5 | 23418 |
| Total Expenditure | 16643.5 | 19176.4 | 20197 |
| Other Income | 104 | 48.6 | 140 |
| Operating Profit | 3551.5 | 3420.1 | 3221 |
| Interest | 255.1 | 160.8 | 240 |
| Exceptional Items | -100.5 | -142 | |
| PBDT | 3296.4 | 3158.8 | 2839 |
| Depreciation | 236.2 | 250.2 | 238 |
| Profit Before Tax | 3060.2 | 2908.6 | 2601 |
| Tax | -28.5 | -195.1 | -68 |
| Profit After Tax | 3088.7 | 3103.7 | 2669 |
| Net Profit | 3088.7 | 3103.7 | 2669 |
| Equity Capital | 636.3 | 636.3 | 636 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 47804 | 50590.2 | 52939 |
| Calculated EPS | 48.54 | 48.78 | 41.97 |
| Diluted Eps After Extraordinary Items | 48.54 | 48.78 | 41.94 |
| Diluted Eps Before Extraordinary Items | 48.54 | 48.78 | 41.94 |
STANDALONE ANNUAL RESULT FOR ZYDUS WELLNESS LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 2162.5 | 2514.8 | 2448 |
| Total Income | 2316.5 | 2650 | 2630 |
| Total Expenditure | 2215.7 | 2131.7 | 2120 |
| Other Income | 154 | 135.2 | 182 |
| Operating Profit | 100.8 | 518.3 | 510 |
| Interest | 20.2 | 11.4 | 26 |
| PBDT | 80.6 | 506.9 | 484 |
| Depreciation | 28.4 | 35.2 | 36 |
| Profit Before Tax | 52.2 | 471.7 | 448 |
| Tax | -74.8 | -192.5 | 111 |
| Profit After Tax | 127 | 664.2 | 337 |
| Net Profit | 127 | 664.2 | 337 |
| Equity Capital | 636.3 | 636.3 | 636 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 39365.5 | 39706.5 | 39723 |
| Calculated EPS | 2 | 10.44 | 5.3 |
| Diluted Eps After Extraordinary Items | 2 | 10.44 | 5.3 |
| Diluted Eps Before Extraordinary Items | 2 | 10.44 | 5.3 |
CONSOLIDATED PROFIT / LOSS FOR ZYDUS WELLNESS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 2013.03 Cr | 2152.71 Cr | 2417.53 Cr | 2491.8 Cr |
| Sales | 2000.02 Cr | 2132.07 Cr | 2405.35 Cr | 2479.2 Cr |
| Net Sales | 1866.67 Cr | 2009.1 Cr | 2254.79 Cr | 2327.8 Cr |
| Increase/Decrease in Stock | -41.13 Cr | 80 Lk | -68.5 Cr | -9.5 Cr |
| Raw Material Consumed | 885.99 Cr | 979.57 Cr | 1214.48 Cr | 1147.9 Cr |
| Opening Raw Materials | 31.11 Cr | 55.32 Cr | 53.65 Cr | 71 Cr |
| Purchases Raw Materials | 767.96 Cr | 883.27 Cr | 1117.51 Cr | 1026.9 Cr |
| Closing Raw Materials | 55.32 Cr | 53.65 Cr | 71.01 Cr | 62.4 Cr |
| Other Direct Purchases / Brought in cost | 142.24 Cr | 94.63 Cr | 114.33 Cr | 112.4 Cr |
| Power & Fuel Cost | 20.91 Cr | 31.42 Cr | 43.25 Cr | 41.5 Cr |
| Electricity & Power | 20.91 Cr | 31.42 Cr | 43.25 Cr | 41.5 Cr |
| Employee Cost | 159.31 Cr | 158.86 Cr | 161.56 Cr | 186.3 Cr |
| Salaries, Wages & Bonus | 147.57 Cr | 142.57 Cr | 148.27 Cr | 169.5 Cr |
| Contributions to EPF & Pension Funds | 7.38 Cr | 12.29 Cr | 8 Cr | 12 Cr |
| Workmen and Staff Welfare Expenses | 4.36 Cr | 4 Cr | 5.29 Cr | 4.8 Cr |
| Other Manufacturing Expenses | 81.51 Cr | 80.05 Cr | 54.44 Cr | 62.8 Cr |
| Sub-contracted / Out sourced services | 33.33 Cr | 33.74 Cr | 0 | 0 |
| Processing Charges | 23.86 Cr | 27.91 Cr | 34.18 Cr | 39.6 Cr |
| Repairs and Maintenance | 13.9 Cr | 12.25 Cr | 13.26 Cr | 15.5 Cr |
| General and Administration Expenses | 59.44 Cr | 51.88 Cr | 60.51 Cr | 90 Cr |
| Rent , Rates & Taxes | 15.58 Cr | 17.4 Cr | 18.63 Cr | 18.7 Cr |
| Insurance | 5.7 Cr | 7.4 Cr | 7.13 Cr | 7.6 Cr |
| Professional and legal fees | 11.23 Cr | 8.85 Cr | 10.58 Cr | 24.9 Cr |
| Traveling and conveyance | 8.05 Cr | 6.4 Cr | 9.77 Cr | 13.4 Cr |
| Selling and Distribution Expenses | 333.81 Cr | 341.58 Cr | 426.44 Cr | 475 Cr |
| Advertisement & Sales Promotion | 254.08 Cr | 258.35 Cr | 325.71 Cr | 366.7 Cr |
| Sales Commissions & Incentives | 16.43 Cr | 18.64 Cr | 20.09 Cr | 23.4 Cr |
| Freight and Forwarding | 63.3 Cr | 64.59 Cr | 80.64 Cr | 84.9 Cr |
| Miscellaneous Expenses | 22.47 Cr | 22.45 Cr | 25.46 Cr | 25.7 Cr |
| Provision for doubtful debts | 0 | 2.71 Cr | 0 | 1 Cr |
| Loss on disposal of fixed assets(net) | 0 | 0 | 14 Lk | 0 |
| Loss on foreign exchange fluctuations | 0 | 88 Lk | 23 Lk | 0 |
| Total Expenditure | 1522.31 Cr | 1666.61 Cr | 1917.64 Cr | 2019.7 Cr |
| Other Income | 8.94 Cr | 12.66 Cr | 4.86 Cr | 14 Cr |
| Interest Received | 6.76 Cr | 9.29 Cr | 3.22 Cr | 11 Cr |
| Profits on sale of Investments | 2.18 Cr | 0 | 1.44 Cr | 2.1 Cr |
| Provision Written Back | 0 | 2.26 Cr | 0 | 0 |
| Foreign Exchange Gains | 0 | 0 | 0 | 10 Lk |
| Operating Profit | 353.3 Cr | 355.15 Cr | 342.01 Cr | 322.1 Cr |
| Interest | 83.8 Cr | 25.51 Cr | 16.08 Cr | 24 Cr |
| InterestonDebenture / Bonds | 60.18 Cr | 0 | 0 | 0 |
| Interest on Term Loan | 0 | 22.56 Cr | 8.2 Cr | 10 Lk |
| Bank Charges etc | 40 Lk | 40 Lk | 31 Lk | 30 Lk |
| PBDT | 269.5 Cr | 329.64 Cr | 325.93 Cr | 298.1 Cr |
| Depreciation | 25.16 Cr | 23.62 Cr | 25.02 Cr | 23.8 Cr |
| Profit Before Taxation & Exceptional Items | 244.34 Cr | 306.02 Cr | 300.91 Cr | 274.3 Cr |
| Exceptional Income / Expenses | -132.13 Cr | 0 | -10.05 Cr | -14.2 Cr |
| Profit Before Tax | 112.21 Cr | 306.02 Cr | 290.86 Cr | 260.1 Cr |
| Provision for Tax | -6.52 Cr | -2.85 Cr | -19.51 Cr | -6.8 Cr |
| Current Income Tax | 0 | 0 | -3 Lk | 60 Lk |
| Deferred Tax | -6.52 Cr | -2.85 Cr | -19.48 Cr | -7 Cr |
| Profit After Tax | 118.73 Cr | 308.87 Cr | 310.37 Cr | 266.9 Cr |
| Consolidated Net Profit | 118.73 Cr | 308.87 Cr | 310.37 Cr | 266.9 Cr |
| Profit Balance B/F | 426.42 Cr | 922.09 Cr | 1198.13 Cr | 1476.6 Cr |
| Appropriations | 545.15 Cr | 1230.96 Cr | 1508.5 Cr | 1743.5 Cr |
| Other Appropriation | -376.94 Cr | 32.83 Cr | 31.87 Cr | 31.8 Cr |
| Equity Dividend % | 50 | 50 | 50 | 50 |
| Earnings Per Share | 18.66 | 48.54 | 48.78 | 41.97 |
| Adjusted EPS | 18.66 | 48.54 | 48.78 | 41.97 |
STANDALONE PROFIT / LOSS FOR ZYDUS WELLNESS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 124.29 Cr | 223.31 Cr | 251.48 Cr | 244.8 Cr |
| Sales | 123.29 Cr | 197.48 Cr | 218.29 Cr | 209.6 Cr |
| Processing Charges / Service Income | 0 | 22.98 Cr | 30.8 Cr | 31.8 Cr |
| Net Sales | 113.83 Cr | 216.25 Cr | 251.48 Cr | 244.8 Cr |
| Increase/Decrease in Stock | -1.27 Cr | 6.54 Cr | 1.4 Cr | 30 Lk |
| Raw Material Consumed | 83.42 Cr | 145.89 Cr | 164.94 Cr | 156.7 Cr |
| Opening Raw Materials | 1.7 Cr | 2.86 Cr | 2.81 Cr | 3.9 Cr |
| Purchases Raw Materials | 84.58 Cr | 146.07 Cr | 165.98 Cr | 157.1 Cr |
| Closing Raw Materials | 2.86 Cr | 3.04 Cr | 3.85 Cr | 4.3 Cr |
| Power & Fuel Cost | 2.36 Cr | 2.63 Cr | 3.28 Cr | 4.1 Cr |
| Electricity & Power | 2.36 Cr | 2.63 Cr | 3.28 Cr | 4.1 Cr |
| Employee Cost | 29.36 Cr | 29.88 Cr | 27.8 Cr | 28.7 Cr |
| Salaries, Wages & Bonus | 27.14 Cr | 27.66 Cr | 25.53 Cr | 25.8 Cr |
| Contributions to EPF & Pension Funds | 1.93 Cr | 1.87 Cr | 1.83 Cr | 2.3 Cr |
| Workmen and Staff Welfare Expenses | 29 Lk | 35 Lk | 44 Lk | 60 Lk |
| Other Manufacturing Expenses | 8.23 Cr | 6.51 Cr | 6.99 Cr | 9.9 Cr |
| Sub-contracted / Out sourced services | 2.85 Cr | 99 Lk | 0 | 0 |
| Processing Charges | 2.92 Cr | 3.02 Cr | 4.66 Cr | 7.1 Cr |
| Repairs and Maintenance | 1.87 Cr | 1.89 Cr | 1.51 Cr | 2.1 Cr |
| General and Administration Expenses | 11.2 Cr | 8.2 Cr | 5.97 Cr | 8.9 Cr |
| Rent , Rates & Taxes | 2.7 Cr | 1.12 Cr | 99 Lk | 70 Lk |
| Insurance | 37 Lk | 65 Lk | 49 Lk | 60 Lk |
| Professional and legal fees | 2.25 Cr | 3.46 Cr | 2.07 Cr | 4.77 Cr |
| Traveling and conveyance | 1.46 Cr | 57 Lk | 16 Lk | 70 Lk |
| Selling and Distribution Expenses | 25.66 Cr | 19.72 Cr | 77 Lk | 70 Lk |
| Advertisement & Sales Promotion | 13.1 Cr | 11.69 Cr | 4 Lk | 0 |
| Sales Commissions & Incentives | 1.91 Cr | 1.13 Cr | 0 | 0 |
| Freight and Forwarding | 10.65 Cr | 6.9 Cr | 73 Lk | 70 Lk |
| Miscellaneous Expenses | 4.59 Cr | 2.2 Cr | 2.02 Cr | 2.7 Cr |
| Loss on disposal of fixed assets(net) | 5 Lk | 1 Lk | 6 Lk | 0 |
| Total Expenditure | 163.55 Cr | 221.57 Cr | 213.17 Cr | 212 Cr |
| Other Income | 66.8 Cr | 15.4 Cr | 13.52 Cr | 18.2 Cr |
| Interest Received | 66.02 Cr | 15.39 Cr | 13.14 Cr | 17.2 Cr |
| Profit on sale of Fixed Assets | 0 | 0 | 0 | 10 Lk |
| Profits on sale of Investments | 78 Lk | 0 | 32 Lk | 70 Lk |
| Foreign Exchange Gains | 0 | 0 | 0 | 20 Lk |
| Operating Profit | 17.08 Cr | 10.08 Cr | 51.83 Cr | 51 Cr |
| Interest | 74.66 Cr | 2.02 Cr | 1.14 Cr | 2.6 Cr |
| InterestonDebenture / Bonds | 72.97 Cr | 0 | 0 | 0 |
| Bank Charges etc | 3 Lk | 1 Lk | 0 | 0 |
| PBDT | -57.58 Cr | 8.06 Cr | 50.69 Cr | 48.4 Cr |
| Depreciation | 3.49 Cr | 2.84 Cr | 3.52 Cr | 3.6 Cr |
| Profit Before Taxation & Exceptional Items | -61.07 Cr | 5.22 Cr | 47.17 Cr | 44.8 Cr |
| Exceptional Income / Expenses | -127.06 Cr | 0 | 0 | 0 |
| Profit Before Tax | -188.13 Cr | 5.22 Cr | 47.17 Cr | 44.8 Cr |
| Provision for Tax | -5.99 Cr | -7.48 Cr | -19.25 Cr | 11.1 Cr |
| Current Income Tax | 0 | 0 | -3 Lk | 50 Lk |
| Deferred Tax | -5.99 Cr | -7.48 Cr | -19.22 Cr | 11 Cr |
| Profit After Tax | -182.14 Cr | 12.7 Cr | 66.42 Cr | 33.7 Cr |
| Consolidated Net Profit | -182.14 Cr | 12.7 Cr | 66.42 Cr | 33.7 Cr |
| Profit Balance B/F | 180.63 Cr | 373.65 Cr | 354.54 Cr | 388.7 Cr |
| Appropriations | -1.51 Cr | 386.35 Cr | 420.96 Cr | 422.4 Cr |
| Other Appropriation | -375.16 Cr | 31.81 Cr | 32.32 Cr | 32.1 Cr |
| Equity Dividend % | 50 | 50 | 50 | 50 |
| Earnings Per Share | -28.62 | 2 | 10.44 | 5.3 |
| Adjusted EPS | -28.62 | 2 | 10.44 | 5.3 |
CONSOLIDATED CASH FLOW FOR ZYDUS WELLNESS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 112.21 Cr | 306.02 Cr | 290.86 Cr | 260.1 Cr |
| Adjustment | 239.91 Cr | 41.26 Cr | 42.05 Cr | 32.8 Cr |
| Changes In working Capital | -65.81 Cr | -106.32 Cr | -239.92 Cr | -43.8 Cr |
| Cash Flow after changes in Working Capital | 286.31 Cr | 240.96 Cr | 92.99 Cr | 249.1 Cr |
| Cash Flow from Operating Activities | 286.51 Cr | 236.85 Cr | 91.71 Cr | 246.4 Cr |
| Cash Flow from Investing Activities | -10.41 Cr | -58.93 Cr | -84.84 Cr | -19.3 Cr |
| Cash Flow from Financing Activitie | -216.21 Cr | -233.82 Cr | -138.49 Cr | -25.7 Cr |
| Net Cash Inflow / Outflow | 59.89 Cr | -55.9 Cr | -131.62 Cr | 201.4 Cr |
| Opening Cash & Cash Equivalents | 192.83 Cr | 252.72 Cr | 169.8 Cr | 38.1 Cr |
| Closing Cash & Cash Equivalent | 252.72 Cr | 196.82 Cr | 38.18 Cr | 239.5 Cr |
STANDALONE CASH FLOW FOR ZYDUS WELLNESS LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | -188.13 Cr | 5.22 Cr | 47.17 Cr | 44.8 Cr |
| Adjustment | 138.97 Cr | -11.25 Cr | -8.02 Cr | -11.8 Cr |
| Changes In working Capital | -5.23 Cr | -7.51 Cr | -2.26 Cr | -6.7 Cr |
| Cash Flow after changes in Working Capital | -54.39 Cr | -13.54 Cr | 36.89 Cr | 26.3 Cr |
| Cash Flow from Operating Activities | -51.95 Cr | -16.27 Cr | 36.67 Cr | 26 Cr |
| Cash Flow from Investing Activities | 816.14 Cr | 39.33 Cr | 66 Lk | -47.2 Cr |
| Cash Flow from Financing Activitie | -709.99 Cr | -37.69 Cr | -79.33 Cr | 15.4 Cr |
| Net Cash Inflow / Outflow | 54.2 Cr | -14.63 Cr | -42 Cr | -5.8 Cr |
| Opening Cash & Cash Equivalents | 29.8 Cr | 84 Cr | 57.35 Cr | 15.4 Cr |
| Closing Cash & Cash Equivalent | 84 Cr | 69.37 Cr | 15.35 Cr | 9.6 Cr |
CONSOLIDATED BALANCE SHEET FOR ZYDUS WELLNESS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 63.63 Cr | 63.63 Cr | 63.63 Cr | 63.6 Cr |
| Equity - Authorised | 100 Cr | 100 Cr | 100 Cr | 100 Cr |
| Equity - Issued | 63.63 Cr | 63.63 Cr | 63.63 Cr | 63.6 Cr |
| Equity Paid Up | 63.63 Cr | 63.63 Cr | 63.63 Cr | 63.6 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 4504.16 Cr | 4780.4 Cr | 5059.02 Cr | 5293.9 Cr |
| Securities Premium | 3537.01 Cr | 3537.01 Cr | 3537.01 Cr | 3537 Cr |
| Profit & Loss Account Balance | 922.09 Cr | 1198.13 Cr | 1476.63 Cr | 1711.7 Cr |
| General Reserves | 45 Cr | 45 Cr | 45 Cr | 45 Cr |
| Reserve excluding Revaluation Reserve | 4504.16 Cr | 4780.4 Cr | 5059.02 Cr | 5293.9 Cr |
| Shareholder's Funds | 4567.79 Cr | 4844.03 Cr | 5122.65 Cr | 5357.5 Cr |
| Unsecured Loans | 312.5 Cr | 62.5 Cr | 0 | 0 |
| Loans - Others | 312.5 Cr | 62.5 Cr | 0 | 0 |
| Deferred Tax Assets / Liabilities | -126.5 Cr | -129.81 Cr | -149.27 Cr | -156.3 Cr |
| Deferred Tax Assets | 137.5 Cr | 143.29 Cr | 162.97 Cr | 172.9 Cr |
| Deferred Tax Liability | 11 Cr | 13.48 Cr | 13.7 Cr | 16.6 Cr |
| Other Long Term Liabilities | 2.4 Cr | 6.03 Cr | 4.73 Cr | 5.6 Cr |
| Long Term Provisions | 12.82 Cr | 12.81 Cr | 101.44 Cr | 15.9 Cr |
| Total Non-Current Liabilities | 201.22 Cr | -48.47 Cr | -43.1 Cr | -134.8 Cr |
| Trade Payables | 438.61 Cr | 364.28 Cr | 313.3 Cr | 362.9 Cr |
| Sundry Creditors | 438.61 Cr | 364.28 Cr | 313.3 Cr | 362.9 Cr |
| Other Current Liabilities | 76.65 Cr | 311.68 Cr | 121.41 Cr | 53.8 Cr |
| Advances received from customers | 9.89 Cr | 6.33 Cr | 6.82 Cr | 7.2 Cr |
| Interest Accrued But Not Due | 10.79 Cr | 3.36 Cr | 2.97 Cr | 2.9 Cr |
| Current maturity - Others | 16 Lk | 0 | 0 | 0 |
| Short Term Borrowings | 237.25 Cr | 69 Cr | 230 Cr | 324 Cr |
| Short Term Provisions | 18.41 Cr | 21.85 Cr | 27.69 Cr | 28.7 Cr |
| Provision for post retirement benefits | 96 Lk | 3.67 Cr | 0 | 0 |
| Total Current Liabilities | 770.92 Cr | 766.81 Cr | 692.4 Cr | 769.4 Cr |
| Total Liabilities | 5539.93 Cr | 5562.37 Cr | 5771.95 Cr | 5992.1 Cr |
| Gross Block | 4857.87 Cr | 4918.77 Cr | 4960.72 Cr | 4933.7 Cr |
| Less: Accumulated Depreciation | 190.47 Cr | 208.83 Cr | 228.34 Cr | 226.2 Cr |
| Net Block | 4667.4 Cr | 4709.94 Cr | 4732.38 Cr | 4707.5 Cr |
| Capital Work in Progress | 3.74 Cr | 11.92 Cr | 12.96 Cr | 9.7 Cr |
| Non Current Investments | 0 | 0 | 0 | 70 Lk |
| Long Term Investment | 0 | 0 | 0 | 70 Lk |
| Unquoted | 0 | 0 | 0 | 70 Lk |
| Long Term Loans & Advances | 16.04 Cr | 26.35 Cr | 117.75 Cr | 24.2 Cr |
| Other Non Current Assets | 5.86 Cr | 46 Lk | 38 Lk | 0 |
| Total Non-Current Assets | 4693.04 Cr | 4748.67 Cr | 4863.47 Cr | 4742.1 Cr |
| Currents Investments | 0 | 27.02 Cr | 69.97 Cr | 76.9 Cr |
| Quoted | 0 | 27.02 Cr | 69.97 Cr | 76.9 Cr |
| Unquoted | 0 | 0 | 0 | 70 Lk |
| Inventories | 364.72 Cr | 361.64 Cr | 457.45 Cr | 467.6 Cr |
| Raw Materials | 55.32 Cr | 53.65 Cr | 71.01 Cr | 62.4 Cr |
| Work-in Progress | 89.44 Cr | 95.4 Cr | 114.86 Cr | 152.7 Cr |
| Finished Goods | 166.29 Cr | 153.77 Cr | 215.39 Cr | 185.1 Cr |
| Packing Materials | 20.18 Cr | 20.58 Cr | 30.88 Cr | 29.2 Cr |
| Stores and Spare | 8.28 Cr | 9.71 Cr | 9.52 Cr | 13.1 Cr |
| Sundry Debtors | 94.28 Cr | 142.32 Cr | 207.81 Cr | 283.3 Cr |
| Debtors more than Six months | 0 | 2.72 Cr | 4.31 Cr | 7 Cr |
| Debtors Others | 97.29 Cr | 141.13 Cr | 205.03 Cr | 278.6 Cr |
| Cash and Bank | 252.72 Cr | 169.8 Cr | 38.18 Cr | 239.5 Cr |
| Cash in hand | 4 Lk | 13 Lk | 10 Lk | 20 Lk |
| Balances at Bank | 252.68 Cr | 169.67 Cr | 38.08 Cr | 239.3 Cr |
| Other Current Assets | 19.3 Cr | 23.81 Cr | 27.99 Cr | 34.5 Cr |
| Prepaid Expenses | 2 Cr | 2.8 Cr | 3.11 Cr | 3.3 Cr |
| Short Term Loans and Advances | 115.87 Cr | 89.11 Cr | 106.42 Cr | 112.5 Cr |
| Advances recoverable in cash or in kind | 9.64 Cr | 5.24 Cr | 7.28 Cr | 8.4 Cr |
| Total Current Assets | 846.89 Cr | 813.7 Cr | 907.82 Cr | 1214.3 Cr |
| Net Current Assets (Including Current Investments) | 75.97 Cr | 46.89 Cr | 215.42 Cr | 444.9 Cr |
| Total Assets | 5539.93 Cr | 5562.37 Cr | 5771.95 Cr | 5992.1 Cr |
| Contingent Liabilities | 320.39 Cr | 357.88 Cr | 378.31 Cr | 340.7 Cr |
| Total Debt | 549.91 Cr | 381.5 Cr | 292.5 Cr | 324 Cr |
| Book Value | 717.87 | 761.28 | 805.07 | 842.37 |
| Adjusted Book Value | 717.87 | 761.28 | 805.07 | 842.37 |
STANDALONE BALANCE SHEET FOR ZYDUS WELLNESS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 63.63 Cr | 63.63 Cr | 63.63 Cr | 63.6 Cr |
| Equity - Authorised | 100 Cr | 100 Cr | 100 Cr | 100 Cr |
| Equity - Issued | 63.63 Cr | 63.63 Cr | 63.63 Cr | 63.6 Cr |
| Equity Paid Up | 63.63 Cr | 63.63 Cr | 63.63 Cr | 63.6 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 3955.66 Cr | 3936.55 Cr | 3970.65 Cr | 3972.3 Cr |
| Securities Premium | 3537.01 Cr | 3537.01 Cr | 3537.01 Cr | 3537 Cr |
| Profit & Loss Account Balance | 373.65 Cr | 354.54 Cr | 388.64 Cr | 390.3 Cr |
| General Reserves | 45 Cr | 45 Cr | 45 Cr | 45 Cr |
| Reserve excluding Revaluation Reserve | 3955.66 Cr | 3936.55 Cr | 3970.65 Cr | 3972.3 Cr |
| Shareholder's Funds | 4019.29 Cr | 4000.18 Cr | 4034.28 Cr | 4035.9 Cr |
| Deferred Tax Assets / Liabilities | -19.98 Cr | -27.46 Cr | -46.86 Cr | -35.9 Cr |
| Deferred Tax Assets | 20.49 Cr | 28.49 Cr | 47.63 Cr | 36.9 Cr |
| Deferred Tax Liability | 51 Lk | 1.03 Cr | 77 Lk | 1 Cr |
| Other Long Term Liabilities | 1.31 Cr | 1.18 Cr | 1.2 Cr | 1.7 Cr |
| Long Term Provisions | 5.79 Cr | 75.2 Cr | 6.32 Cr | 6.2 Cr |
| Total Non-Current Liabilities | -12.88 Cr | 48.92 Cr | -39.34 Cr | -28 Cr |
| Trade Payables | 35.58 Cr | 31.16 Cr | 20.18 Cr | 19.3 Cr |
| Sundry Creditors | 35.58 Cr | 31.16 Cr | 20.18 Cr | 19.3 Cr |
| Other Current Liabilities | 7.43 Cr | 9.63 Cr | 7.21 Cr | 4.4 Cr |
| Advances received from customers | 1.75 Cr | 1.59 Cr | 12 Lk | 10 Lk |
| Interest Accrued But Not Due | 0 | 13 Lk | 0 | 0 |
| Current maturity - Others | 16 Lk | 0 | 0 | 0 |
| Short Term Borrowings | 49.75 Cr | 46 Cr | 0 | 50 Cr |
| Short Term Provisions | 79 Lk | 64 Lk | 1.13 Cr | 1.3 Cr |
| Provision for post retirement benefits | 63 Lk | 56 Lk | 0 | 0 |
| Total Current Liabilities | 93.55 Cr | 87.43 Cr | 28.52 Cr | 75 Cr |
| Total Liabilities | 4099.96 Cr | 4136.53 Cr | 4023.46 Cr | 4082.9 Cr |
| Gross Block | 81.92 Cr | 85.57 Cr | 94.42 Cr | 96.5 Cr |
| Less: Accumulated Depreciation | 37.87 Cr | 40.57 Cr | 39.85 Cr | 42.4 Cr |
| Net Block | 44.05 Cr | 45 Cr | 54.57 Cr | 54.1 Cr |
| Capital Work in Progress | 87 Lk | 1.77 Cr | 47 Lk | 4 Cr |
| Non Current Investments | 3671.25 Cr | 3671.25 Cr | 3671.25 Cr | 3671.3 Cr |
| Long Term Investment | 3671.25 Cr | 3671.25 Cr | 3671.25 Cr | 3671.3 Cr |
| Unquoted | 3671.25 Cr | 3671.25 Cr | 3671.25 Cr | 3671.3 Cr |
| Long Term Loans & Advances | 251.48 Cr | 296.73 Cr | 127.12 Cr | 221.7 Cr |
| Other Non Current Assets | 7 Lk | 0 | 0 | 0 |
| Total Non-Current Assets | 3967.72 Cr | 4014.75 Cr | 3853.41 Cr | 3951.1 Cr |
| Currents Investments | 0 | 12.02 Cr | 26.86 Cr | 4.8 Cr |
| Quoted | 0 | 12.02 Cr | 26.86 Cr | 4.8 Cr |
| Unquoted | 3671.25 Cr | 3671.25 Cr | 3671.25 Cr | 3671.3 Cr |
| Inventories | 15.18 Cr | 9.05 Cr | 9 Cr | 10.1 Cr |
| Raw Materials | 2.86 Cr | 3.04 Cr | 3.85 Cr | 4.3 Cr |
| Work-in Progress | 1 Lk | 4 Lk | 5 Lk | 10 Lk |
| Finished Goods | 10.83 Cr | 4.27 Cr | 2.86 Cr | 2.4 Cr |
| Packing Materials | 1.15 Cr | 1.38 Cr | 1.63 Cr | 1.8 Cr |
| Stores and Spare | 16 Lk | 16 Lk | 4 Lk | 0 |
| Sundry Debtors | 1.71 Cr | 11.02 Cr | 2.91 Cr | 7.8 Cr |
| Debtors more than Six months | 0 | 13 Lk | 9 Lk | 10 Lk |
| Debtors Others | 1.74 Cr | 10.97 Cr | 2.9 Cr | 7.8 Cr |
| Cash and Bank | 84 Cr | 57.35 Cr | 15.35 Cr | 9.6 Cr |
| Cash in hand | 0 | 2 Lk | 2 Lk | 0 |
| Balances at Bank | 84 Cr | 57.33 Cr | 15.33 Cr | 9.6 Cr |
| Other Current Assets | 6.91 Cr | 7.51 Cr | 6.97 Cr | 10.3 Cr |
| Interest accrued and or due on loans | 6.72 Cr | 5.56 Cr | 5.04 Cr | 8.3 Cr |
| Prepaid Expenses | 19 Lk | 17 Lk | 15 Lk | 20 Lk |
| Short Term Loans and Advances | 24.44 Cr | 24.83 Cr | 108.96 Cr | 89.2 Cr |
| Advances recoverable in cash or in kind | 1.35 Cr | 62 Lk | 69 Lk | 1.2 Cr |
| Total Current Assets | 132.24 Cr | 121.78 Cr | 170.05 Cr | 131.8 Cr |
| Net Current Assets (Including Current Investments) | 38.69 Cr | 34.35 Cr | 141.53 Cr | 56.8 Cr |
| Total Assets | 4099.96 Cr | 4136.53 Cr | 4023.46 Cr | 4082.9 Cr |
| Contingent Liabilities | 6.74 Cr | 7.15 Cr | 7.46 Cr | 9.4 Cr |
| Total Debt | 49.91 Cr | 46 Cr | 0 | 50 Cr |
| Book Value | 631.67 | 628.66 | 634.02 | 634.58 |
| Adjusted Book Value | 631.67 | 628.66 | 634.02 | 634.58 |
FINANCIAL RATIOS (CONSOLIDATED) FOR ZYDUS WELLNESS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 18.66 | 48.54 | 48.78 | 41.97 |
| CEPS(Rs) | 22.61 | 52.25 | 52.71 | 45.71 |
| DPS(Rs) | 5 | 5 | 5 | 5 |
| Book NAV/Share(Rs) | 717.87 | 761.28 | 805.07 | 842.37 |
| Tax Rate(%) | -5.81 | -0.93 | -6.71 | -2.61 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 17.11 | 15.91 | 13.95 | 12.36 |
| EBIT Margin(%) | 9.74 | 15.4 | 12.7 | 11.4 |
| Pre Tax Margin(%) | 5.57 | 14.22 | 12.03 | 10.44 |
| PAT Margin (%) | 5.9 | 14.35 | 12.84 | 10.71 |
| Cash Profit Margin (%) | 7.15 | 15.45 | 13.87 | 11.67 |
| Performance Ratios | ||||
| ROA(%) | 2.16 | 5.56 | 5.43 | 4.57 |
| ROE(%) | 2.96 | 6.56 | 6.23 | 5.09 |
| ROCE(%) | 3.88 | 6.41 | 5.77 | 5.12 |
| Asset Turnover(x) | 0.37 | 0.39 | 0.42 | 0.43 |
| Sales/Fixed Asset(x) | 0.41 | 0.44 | 0.49 | 0.5 |
| Working Capital/Sales(x) | 26.5 | 45.91 | 11.22 | 5.6 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 2.41 | 2.27 | 2.04 | 1.99 |
| Receivable days | 19.26 | 20.06 | 26.43 | 35.97 |
| Inventory Days | 59.57 | 61.58 | 61.83 | 67.75 |
| Payable days | 113.19 | 149.46 | 107.91 | 108.4 |
| Valuation Parameters | ||||
| PER(x) | 105.73 | 30.92 | 31.78 | 35.05 |
| PCE(x) | 87.24 | 28.72 | 29.4 | 32.18 |
| Price/Book(x) | 2.75 | 1.97 | 1.93 | 1.75 |
| Yield(%) | 0.25 | 0.33 | 0.32 | 0.34 |
| EV/Net Sales(x) | 6.88 | 4.86 | 4.49 | 4.06 |
| EV/Core EBITDA(x) | 36.37 | 27.48 | 29.58 | 29.31 |
| EV/EBIT(x) | 65.56 | 29.44 | 32.96 | 33.23 |
| EV/CE(x) | 2.32 | 1.75 | 1.75 | 1.66 |
| M Cap / Sales | 6.72 | 4.75 | 4.37 | 4.02 |
| Growth Ratio | ||||
| Net Sales Growth(%) | 5.65 | 7.63 | 12.23 | 3.24 |
| Core EBITDA Growth(%) | 6.49 | 0.52 | -3.7 | -5.85 |
| EBIT Growth(%) | -24.95 | 69.14 | -7.42 | -7.46 |
| PAT Growth(%) | -16.22 | 160.15 | 0.49 | -14.01 |
| EPS Growth(%) | -24.08 | 160.15 | 0.49 | -14.01 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.12 | 0.08 | 0.06 | 0.06 |
| Current Ratio(x) | 1.1 | 1.06 | 1.31 | 1.58 |
| Quick Ratio(x) | 0.63 | 0.59 | 0.65 | 0.97 |
| Interest Cover(x) | 2.34 | 13 | 19.09 | 11.84 |
| Total Debt/Mcap(x) | 0.04 | 0.04 | 0.03 | 0.03 |
FINANCIAL RATIOS (STANDALONE) FOR ZYDUS WELLNESS LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | -28.62 | 2 | 10.44 | 5.3 |
| CEPS(Rs) | -28.08 | 2.44 | 10.99 | 5.86 |
| DPS(Rs) | 5 | 5 | 5 | 5 |
| Book NAV/Share(Rs) | 631.67 | 628.66 | 634.02 | 634.58 |
| Tax Rate(%) | 3.18 | -143.3 | -40.81 | 24.78 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | -40 | -2.38 | 15.23 | 13.4 |
| EBIT Margin(%) | -91.29 | 3.24 | 19.21 | 19.36 |
| Pre Tax Margin(%) | -151.36 | 2.34 | 18.76 | 18.3 |
| PAT Margin (%) | -146.54 | 5.69 | 26.41 | 13.77 |
| Cash Profit Margin (%) | -143.74 | 6.96 | 27.81 | 15.24 |
| Performance Ratios | ||||
| ROA(%) | -4.1 | 0.31 | 1.64 | 0.83 |
| ROE(%) | -5.04 | 0.32 | 1.65 | 0.84 |
| ROCE(%) | -2.58 | 0.18 | 1.2 | 1.17 |
| Asset Turnover(x) | 0.03 | 0.05 | 0.06 | 0.06 |
| Sales/Fixed Asset(x) | 1.56 | 2.67 | 2.79 | 2.57 |
| Working Capital/Sales(x) | 3.21 | 6.5 | 1.78 | 4.31 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 0.64 | 0.38 | 0.36 | 0.39 |
| Receivable days | 3.32 | 10.4 | 10.11 | 7.98 |
| Inventory Days | 40.41 | 19.8 | 13.1 | 14.24 |
| Payable days | 80.6 | 79.91 | 56.33 | 45.92 |
| Valuation Parameters | ||||
| PER(x) | 0 | 751.92 | 148.48 | 277.6 |
| PCE(x) | -70.27 | 614.5 | 141.01 | 250.8 |
| Price/Book(x) | 3.12 | 2.39 | 2.44 | 2.32 |
| Yield(%) | 0.25 | 0.33 | 0.32 | 0.34 |
| EV/Net Sales(x) | 109.98 | 44.11 | 39.15 | 38.38 |
| EV/Core EBITDA(x) | 732.95 | 946.22 | 189.98 | 184.22 |
| EV/EBIT(x) | -110.33 | 1317.39 | 203.82 | 198.21 |
| EV/CE(x) | 3.05 | 2.31 | 2.45 | 2.3 |
| M Cap / Sales | 110.28 | 44.16 | 39.22 | 38.21 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -25.97 | 89.98 | 16.29 | -2.55 |
| Core EBITDA Growth(%) | -80.73 | -40.98 | 414.19 | -1.54 |
| EBIT Growth(%) | -232.95 | 106.38 | 567.27 | -1.86 |
| PAT Growth(%) | -347.19 | 106.97 | 422.99 | -49.25 |
| EPS Growth(%) | -305.23 | 106.97 | 423 | -49.25 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.01 | 0.01 | 0 | 0.01 |
| Current Ratio(x) | 1.41 | 1.39 | 5.96 | 1.76 |
| Quick Ratio(x) | 1.25 | 1.29 | 5.65 | 1.62 |
| Interest Cover(x) | -1.52 | 3.58 | 42.38 | 18.23 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0.01 |
SHARE HOLDING PATTERN FOR ZYDUS WELLNESS LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 65.14 | 65.35 | 65.35 | 66.45 | 67.10 | 68.54 | 69.15 | 69.62 | 69.62 | 69.62 |
| FII % | 2.38 | 3.24 | 3.83 | 3.87 | 3.23 | 3.42 | 3.25 | 3.26 | 3.29 | 3.36 |
| DII % | 12.64 | 11.44 | 11.46 | 11.44 | 11.37 | 11.58 | 10.28 | 10.16 | 10.20 | 7.53 |
| Public % | 7.37 | 7.63 | 7.47 | 7.50 | 7.62 | 7.81 | 7.93 | 7.71 | 7.65 | 6.67 |
PEER COMPARISON FOR ZYDUS WELLNESS LIMITED
CORPORATE ACTIONS FOR ZYDUS WELLNESS
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 29-Oct-2024 | Board Meeting - Quarterly Results | 11-Nov-2024 |
| BSE 18-Jul-2024 | Board Meeting - Quarterly Results | 02-Aug-2024 |
| BSE 14-May-2024 | AGM - Inter alia, have recommended Final Dividend of ? 5.00 (@ 50%) per equity share of ? 10/- each, subject to approval of the members at the ensuing Annual General Meeting scheduled to be held on August 2, 2024. | 02-Aug-2024 |
| BSE 14-May-2024 | Dividend - Rs.5.0000 per share(50%)Final Dividend | |
| BSE 06-May-2024 | Board Meeting - Final Dividend & Audited Results | 14-May-2024 |
| BSE 29-Jan-2024 | Board Meeting - Quarterly Results | 08-Feb-2024 |
| BSE 27-Oct-2023 | Board Meeting - Quarterly Results | 06-Nov-2023 |
| BSE 24-Jul-2023 | Board Meeting - Quarterly Results | 03-Aug-2023 |
| BSE 17-May-2023 | Dividend - Rs.5.0000 per share(50%)Final Dividend | |
| BSE 08-May-2023 | Board Meeting - Final Dividend & Audited Results | 17-May-2023 |
| BSE 24-Jan-2023 | Board Meeting - Quarterly Results | 02-Feb-2023 |
| BSE 01-Nov-2022 | Board Meeting - Quarterly Results | 10-Nov-2022 |
| BSE 21-Jul-2022 | Board Meeting - Quarterly Results | 29-Jul-2022 |
| BSE 17-May-2022 | Dividend - Rs.5.0000 per share(50%)Final Dividend | |
| BSE 17-May-2022 | AGM - Inter alia, approved: 1. Twenty Eighth Annual General Meeting of the members of the Company is scheduled to be held on Friday, July 29, 2022 through Video Conference / Other Audio Visual Means. 2. The Board of Directors at their meeting held today have recommended Final Dividend of Rs. 5.00/- (@ 50%) per equity share of Rs. 10/- each, subject to approval of the members at the ensuing Annual Genera... | 29-Jul-2022 |
| BSE 10-May-2022 | Board Meeting - Final Dividend & Audited Results | 17-May-2022 |
| BSE 25-Jan-2022 | Board Meeting - Quarterly Results | 02-Feb-2022 |
| BSE 20-Oct-2021 | Board Meeting - Quarterly Results | 28-Oct-2021 |
CORPORATE ANNOUNCEMENTS FOR ZYDUS WELLNESS
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 30-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Zydus Wellness to acquire 100% stake in Naturell (India) Private Limited a strategic leap into healthy consumer snacking space |
| BSE 30-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Acquisition Acquisition of 100% equity share capital of Naturell (India) Private Limited |
| BSE 30-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate under Reg. 39(3) of the SEBI (LODR) Regulations 2015 |
| BSE 30-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Schedule of Analyst / Institutional Investors Call post announcement of unaudited financial results for the quarter and half year ended on September 30 2024 |
| BSE 29-Oct-2024 | Intimation FILE | Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2024 ZYDUS WELLNESS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve unaudited financial results for the quarter and half year ended on September 30 2024 |
| BSE 23-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate under Reg. 39(3) of the SEBI (LODR) Regulations 2015 |
| BSE 14-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Management Change in Senior Management |
| BSE 07-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Reg. 74(5) of the SEBI (DP) Regulations 2018 |
| BSE 01-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Resignation of Director Resignation of Mr. Ashish P. Bhargava as a Nominee Director w.e.f. September 30 2024 |
| BSE 25-Sep-2024 | Intimation FILE | Closure of Trading Window Intimation of Trading Window closure |
| BSE 24-Sep-2024 | General Announcements FILE | Receipt Of Order Under VAT And CST Act From The Excise And Taxation Officer Chandigarh Receipt of Order under VAT and CST Act from the Excise and Taxation Officer Chandigarh |
| BSE 18-Sep-2024 | General Announcements FILE | Receipt Of Order Under CGST Act From The Office Of Assistant Commissioner Bihar Receipt of Order under CGST Act from the office of Assisstant Commissioner Bihar |
| BSE 31-Aug-2024 | General Announcements FILE | Receipt Of Order Under CGST Act From The Superintendent Mumbai East Commissionerate Receipt of Order under CGST Act from the Superintendent Mumbai East Commissionerate |
| BSE 31-Aug-2024 | General Announcements FILE | Receipt Of Order Under CGST Act From The Office Of Superintendent Bhiwandi Receipt of Order under CGST Act from the Office of Superintendent Bhiwandi |
| BSE 29-Aug-2024 | General Announcements FILE | Receipt Of Order Under CGST Act Receipt of Order under CGST Act |
| BSE 22-Aug-2024 | General Announcements FILE | Transcript Of 30Th Annual General Meeting Transcript of 30th Annual General Meeting |
| BSE 21-Aug-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate under reg. 39(3) of the SEBI (LODR) Regulations 2015 |
| BSE 19-Aug-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate under Reg. 39(3) of the SEBI (LODR) Regulations 2015 |
| BSE 14-Aug-2024 | General Announcements FILE | Receipt Of Order Under CGST Act Receipt of Order under CGST Act |
| BSE 08-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Schedule of Analyst / Institutional Investorss Group Meeting |
| BSE 08-Aug-2024 | General FILE | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Threpsi Care LLP |
| BSE 07-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of the Earnings Conference Call held on August 2 2024 |
| BSE 07-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 Disclosure under SEBI Insider Trading Regulations |
| BSE 05-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Schedule of Analyst / Institutional Investors meet |
| BSE 04-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper publication with regard to Unaudited Financial Results for the quarter ended on June 30 2024 |
| BSE 02-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 Revised Code of Fair Disclosure and Conduct and Code for Prevention of Insider Trading |
| BSE 02-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Voting results of 30th AGM held on August 2 2024 |
| BSE 02-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Consolidated Results on remote e-voting and e-voting during 30th AGM held on August 2 2024 |
| BSE 02-Aug-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Proceedings of the 30th AGM held on August 2 2024 |
| BSE 02-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Audio recording of the Investor call on unaudited financial results for the quarter ended on June 30 2024 |
INSIDER TRADING FOR ZYDUS WELLNESS
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 03-Jun-2024 03-Jun-2024 | Buy Market | 2,000 @ 0.00 (0.00 %) | Rupa Nitinkumar Parekh |
| BSE 11-Mar-2024 11-Mar-2024 | Buy Market | 186,353 @ 0.00 (0.29 %) | ZYDUS FAMILY TRUST |
| BSE 11-Mar-2024 11-Mar-2024 | Sell Others | 183,093 @ 0.00 (0.00 %) | Nitinbhai Raojibhai Desai and Mukesh Mangalbhai Patel Harismruti Family Trust |
| BSE 23-Feb-2024 23-Feb-2024 | Buy Others | 110,000 @ 0.00 (0.17 %) | ZYDUS FAMILY TRUST |
| BSE 08-Aug-2023 08-Aug-2023 | Buy Market | 52,285 @ 0.00 (0.09 %) | ZYDUS FAMILY TRUST |
| BSE 07-Aug-2023 07-Aug-2023 | Buy Market | 320,697 @ 0.00 (0.51 %) | ZYDUS FAMILY TRUST |
| BSE 07-Aug-2023 07-Aug-2023 | Buy Market | 323,868 @ 0.00 (0.50 %) | ZYDUS FAMILY TRUST |
| BSE 26-Jun-2023 26-Jun-2023 | Buy Market | 259,348 @ 0.00 (0.40 %) | ZYDUS FAMILY TRUST |
| BSE 07-Jun-2023 07-Jun-2023 | Buy Market | 99,035 @ 0.00 (0.16 %) | ZYDUS FAMILY TRUST |
| BSE 06-Jun-2023 06-Jun-2023 | Buy Market | 61,000 @ 0.00 (0.10 %) | ZYDUS FAMILY TRUST |
| BSE 28-Mar-2023 28-Mar-2023 | Buy Market | 150 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 28-Mar-2023 28-Mar-2023 | Buy Market | 247 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 27-Mar-2023 27-Mar-2023 | Buy Market | 1,124 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 27-Mar-2023 27-Mar-2023 | Buy Market | 7,942 @ 0.00 (0.01 %) | ZYDUS FAMILY TRUST |
| BSE 23-Mar-2023 23-Mar-2023 | Buy Market | 3 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 23-Mar-2023 23-Mar-2023 | Buy Market | 397 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 22-Mar-2023 22-Mar-2023 | Buy Market | 449 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 21-Mar-2023 21-Mar-2023 | Buy Market | 5,877 @ 0.00 (0.01 %) | ZYDUS FAMILY TRUST |
| BSE 21-Mar-2023 21-Mar-2023 | Buy Market | 83,210 @ 0.00 (0.13 %) | ZYDUS FAMILY TRUST |
| BSE 15-Mar-2023 15-Mar-2023 | Buy Market | 1,203 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 15-Mar-2023 15-Mar-2023 | Buy Market | 7,493 @ 0.00 (0.01 %) | ZYDUS FAMILY TRUST |
| BSE 14-Mar-2023 14-Mar-2023 | Buy Market | 1,507 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 14-Mar-2023 14-Mar-2023 | Buy Market | 9,400 @ 0.00 (0.02 %) | ZYDUS FAMILY TRUST |
| BSE 13-Mar-2023 13-Mar-2023 | Buy Market | 6,077 @ 0.00 (0.01 %) | ZYDUS FAMILY TRUST |
| BSE 13-Mar-2023 13-Mar-2023 | Buy Market | 11,605 @ 0.00 (0.02 %) | ZYDUS FAMILY TRUST |
| BSE 01-Mar-2023 01-Mar-2023 | Buy Market | 1,688 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 01-Mar-2023 01-Mar-2023 | Buy Market | 5,263 @ 0.00 (0.01 %) | ZYDUS FAMILY TRUST |
| BSE 28-Feb-2023 28-Feb-2023 | Buy Market | 58 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
| BSE 28-Feb-2023 28-Feb-2023 | Buy Market | 2,159 @ 0.00 (0.01 %) | ZYDUS FAMILY TRUST |
| BSE 27-Feb-2023 27-Feb-2023 | Buy Market | 59 @ 0.00 (0.00 %) | ZYDUS FAMILY TRUST |
BULK BLOCK DEALS FOR ZYDUS WELLNESS LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 07-Aug-2023 | Buy BULK | 320,697 @ 1460.00 | ZYDUS FAMILY TRUST |
DIVIDEND BY ZYDUS WELLNESS LIMITED
| Ex Dividend Date | Dividend Type | Dividend |
|---|---|---|
| 19-Jul-2024 | DIVIDEND | 5 |
| 21-Jul-2023 | DIVIDEND | 5 |
| 14-Jul-2022 | DIVIDEND | 5 |
| 14-Jul-2021 | DIVIDEND | 5 |
SPLIT / BONUS BY ZYDUS WELLNESS LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed